Related Experiment Videos
Type 2 diabetes: new drugs, new perspectives
1Joslin Diabetes Center, Boston, USA.
Hospital Practice (1995)
|September 22, 2001
Summary
Early detection of disease is rising. While diet and exercise are key, new medications like thiazolidinediones, a novel class of insulin sensitizers, offer additional treatment options.
Area of Science:
- Endocrinology and Metabolism
Background:
- Increasing detection rates of the disease at younger ages.
- Established therapeutic mainstays include diet and exercise.
- Emerging pharmacological interventions target specific pathophysiologic mechanisms.
Purpose of the Study:
- To introduce and describe a novel class of therapeutic agents.
- To highlight advancements in disease management.
Main Methods:
- Review of current therapeutic strategies.
- Introduction of a new drug class: thiazolidinediones.
Main Results:
- Thiazolidinediones represent a novel class of insulin sensitizers.
- These drugs offer a new approach to managing the disease.
Conclusions:
- The availability of thiazolidinediones expands treatment options for the disease.
- Novel drug classes provide targeted therapies for evolving patient needs.